nodes	percent_of_prediction	percent_of_DWPC	metapath
Mafenide—Accidental exposure to product—Tamoxifen—pancreatic cancer	0.156	0.165	CcSEcCtD
Mafenide—Accidental ingestion—Tamoxifen—pancreatic cancer	0.156	0.165	CcSEcCtD
Mafenide—Disseminated intravascular coagulation—Sunitinib—pancreatic cancer	0.0353	0.0373	CcSEcCtD
Mafenide—Tachypnoea—Gemcitabine—pancreatic cancer	0.0296	0.0313	CcSEcCtD
Mafenide—Blister—Tamoxifen—pancreatic cancer	0.0204	0.0216	CcSEcCtD
Mafenide—Blister—Erlotinib—pancreatic cancer	0.0202	0.0214	CcSEcCtD
Mafenide—Disseminated intravascular coagulation—Docetaxel—pancreatic cancer	0.0201	0.0213	CcSEcCtD
Mafenide—Blister—Sunitinib—pancreatic cancer	0.0175	0.0185	CcSEcCtD
Mafenide—CA9—gall bladder—pancreatic cancer	0.0146	0.267	CbGeAlD
Mafenide—Blister—Fluorouracil—pancreatic cancer	0.0138	0.0146	CcSEcCtD
Mafenide—Swelling—Tamoxifen—pancreatic cancer	0.0121	0.0128	CcSEcCtD
Mafenide—Haemolytic anaemia—Erlotinib—pancreatic cancer	0.0117	0.0124	CcSEcCtD
Mafenide—Dermatitis bullous—Tamoxifen—pancreatic cancer	0.0112	0.0118	CcSEcCtD
Mafenide—Dermatitis bullous—Erlotinib—pancreatic cancer	0.0111	0.0117	CcSEcCtD
Mafenide—Burning sensation—Docetaxel—pancreatic cancer	0.0103	0.0109	CcSEcCtD
Mafenide—Dermatitis bullous—Sunitinib—pancreatic cancer	0.00958	0.0101	CcSEcCtD
Mafenide—CA9—islet of Langerhans—pancreatic cancer	0.00954	0.175	CbGeAlD
Mafenide—Face oedema—Sunitinib—pancreatic cancer	0.00884	0.00935	CcSEcCtD
Mafenide—Pancytopenia—Tamoxifen—pancreatic cancer	0.00877	0.00928	CcSEcCtD
Mafenide—Swelling—Fluorouracil—pancreatic cancer	0.00819	0.00866	CcSEcCtD
Mafenide—Dermatitis bullous—Gemcitabine—pancreatic cancer	0.00769	0.00813	CcSEcCtD
Mafenide—Dermatitis bullous—Fluorouracil—pancreatic cancer	0.00756	0.00799	CcSEcCtD
Mafenide—Pancytopenia—Sunitinib—pancreatic cancer	0.00751	0.00795	CcSEcCtD
Mafenide—Haemoglobin—Tamoxifen—pancreatic cancer	0.00743	0.00786	CcSEcCtD
Mafenide—Haemorrhage—Tamoxifen—pancreatic cancer	0.00739	0.00782	CcSEcCtD
Mafenide—Haemoglobin—Erlotinib—pancreatic cancer	0.00735	0.00778	CcSEcCtD
Mafenide—Haemorrhage—Erlotinib—pancreatic cancer	0.00732	0.00774	CcSEcCtD
Mafenide—Bone marrow depression—Epirubicin—pancreatic cancer	0.00717	0.00759	CcSEcCtD
Mafenide—Face oedema—Gemcitabine—pancreatic cancer	0.00709	0.0075	CcSEcCtD
Mafenide—Hyperventilation—Epirubicin—pancreatic cancer	0.00704	0.00744	CcSEcCtD
Mafenide—Burning sensation—Epirubicin—pancreatic cancer	0.00697	0.00737	CcSEcCtD
Mafenide—Blister—Epirubicin—pancreatic cancer	0.00672	0.00711	CcSEcCtD
Mafenide—Bone marrow depression—Doxorubicin—pancreatic cancer	0.00664	0.00702	CcSEcCtD
Mafenide—CA7—digestive system—pancreatic cancer	0.00652	0.12	CbGeAlD
Mafenide—Hyperventilation—Doxorubicin—pancreatic cancer	0.00651	0.00689	CcSEcCtD
Mafenide—Burning sensation—Doxorubicin—pancreatic cancer	0.00645	0.00682	CcSEcCtD
Mafenide—Erythema—Tamoxifen—pancreatic cancer	0.00644	0.00681	CcSEcCtD
Mafenide—Erythema—Erlotinib—pancreatic cancer	0.00637	0.00674	CcSEcCtD
Mafenide—Haemoglobin—Sunitinib—pancreatic cancer	0.00637	0.00673	CcSEcCtD
Mafenide—Haemorrhage—Sunitinib—pancreatic cancer	0.00633	0.0067	CcSEcCtD
Mafenide—Blister—Doxorubicin—pancreatic cancer	0.00622	0.00658	CcSEcCtD
Mafenide—Eosinophilia—Fluorouracil—pancreatic cancer	0.00618	0.00654	CcSEcCtD
Mafenide—Pancytopenia—Gemcitabine—pancreatic cancer	0.00603	0.00638	CcSEcCtD
Mafenide—Pancytopenia—Fluorouracil—pancreatic cancer	0.00593	0.00627	CcSEcCtD
Mafenide—Swelling—Docetaxel—pancreatic cancer	0.00591	0.00625	CcSEcCtD
Mafenide—CA9—digestive system—pancreatic cancer	0.00573	0.105	CbGeAlD
Mafenide—CA2—gall bladder—pancreatic cancer	0.00553	0.102	CbGeAlD
Mafenide—Erythema—Sunitinib—pancreatic cancer	0.00551	0.00583	CcSEcCtD
Mafenide—Dermatitis bullous—Docetaxel—pancreatic cancer	0.00545	0.00577	CcSEcCtD
Mafenide—Haemoglobin—Irinotecan—pancreatic cancer	0.00524	0.00555	CcSEcCtD
Mafenide—Haemorrhage—Irinotecan—pancreatic cancer	0.00522	0.00552	CcSEcCtD
Mafenide—Haemoglobin—Gemcitabine—pancreatic cancer	0.00511	0.0054	CcSEcCtD
Mafenide—Haemorrhage—Gemcitabine—pancreatic cancer	0.00508	0.00537	CcSEcCtD
Mafenide—Haemoglobin—Fluorouracil—pancreatic cancer	0.00502	0.00531	CcSEcCtD
Mafenide—Haemorrhage—Fluorouracil—pancreatic cancer	0.005	0.00528	CcSEcCtD
Mafenide—Pain—Tamoxifen—pancreatic cancer	0.00449	0.00475	CcSEcCtD
Mafenide—Pain—Erlotinib—pancreatic cancer	0.00444	0.0047	CcSEcCtD
Mafenide—Erythema—Gemcitabine—pancreatic cancer	0.00442	0.00468	CcSEcCtD
Mafenide—Erythema—Fluorouracil—pancreatic cancer	0.00435	0.0046	CcSEcCtD
Mafenide—Pancytopenia—Docetaxel—pancreatic cancer	0.00428	0.00452	CcSEcCtD
Mafenide—CA12—digestive system—pancreatic cancer	0.00424	0.0778	CbGeAlD
Mafenide—Urticaria—Tamoxifen—pancreatic cancer	0.00417	0.00441	CcSEcCtD
Mafenide—Pain—Sunitinib—pancreatic cancer	0.00385	0.00407	CcSEcCtD
Mafenide—Pruritus—Tamoxifen—pancreatic cancer	0.00372	0.00393	CcSEcCtD
Mafenide—Dermatitis bullous—Epirubicin—pancreatic cancer	0.00368	0.00389	CcSEcCtD
Mafenide—Pruritus—Erlotinib—pancreatic cancer	0.00368	0.00389	CcSEcCtD
Mafenide—CA2—islet of Langerhans—pancreatic cancer	0.00362	0.0665	CbGeAlD
Mafenide—Haemoglobin—Docetaxel—pancreatic cancer	0.00362	0.00383	CcSEcCtD
Mafenide—Haemorrhage—Docetaxel—pancreatic cancer	0.00361	0.00381	CcSEcCtD
Mafenide—Diarrhoea—Tamoxifen—pancreatic cancer	0.00359	0.0038	CcSEcCtD
Mafenide—Diarrhoea—Erlotinib—pancreatic cancer	0.00356	0.00376	CcSEcCtD
Mafenide—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.0034	0.0036	CcSEcCtD
Mafenide—Face oedema—Epirubicin—pancreatic cancer	0.00339	0.00359	CcSEcCtD
Mafenide—Rash—Tamoxifen—pancreatic cancer	0.00331	0.0035	CcSEcCtD
Mafenide—Dermatitis—Tamoxifen—pancreatic cancer	0.00331	0.0035	CcSEcCtD
Mafenide—Rash—Erlotinib—pancreatic cancer	0.00328	0.00347	CcSEcCtD
Mafenide—Dermatitis—Erlotinib—pancreatic cancer	0.00327	0.00346	CcSEcCtD
Mafenide—Pruritus—Sunitinib—pancreatic cancer	0.00318	0.00337	CcSEcCtD
Mafenide—Pain—Irinotecan—pancreatic cancer	0.00317	0.00335	CcSEcCtD
Mafenide—Face oedema—Doxorubicin—pancreatic cancer	0.00314	0.00332	CcSEcCtD
Mafenide—Erythema—Docetaxel—pancreatic cancer	0.00314	0.00332	CcSEcCtD
Mafenide—Pain—Gemcitabine—pancreatic cancer	0.00309	0.00327	CcSEcCtD
Mafenide—Diarrhoea—Sunitinib—pancreatic cancer	0.00308	0.00326	CcSEcCtD
Mafenide—Pain—Fluorouracil—pancreatic cancer	0.00304	0.00321	CcSEcCtD
Mafenide—Eosinophilia—Epirubicin—pancreatic cancer	0.00301	0.00318	CcSEcCtD
Mafenide—Pancytopenia—Epirubicin—pancreatic cancer	0.00289	0.00305	CcSEcCtD
Mafenide—Rash—Sunitinib—pancreatic cancer	0.00284	0.003	CcSEcCtD
Mafenide—Dermatitis—Sunitinib—pancreatic cancer	0.00283	0.003	CcSEcCtD
Mafenide—Urticaria—Fluorouracil—pancreatic cancer	0.00282	0.00298	CcSEcCtD
Mafenide—Eosinophilia—Doxorubicin—pancreatic cancer	0.00278	0.00294	CcSEcCtD
Mafenide—Pancytopenia—Doxorubicin—pancreatic cancer	0.00267	0.00282	CcSEcCtD
Mafenide—Pruritus—Gemcitabine—pancreatic cancer	0.00255	0.0027	CcSEcCtD
Mafenide—CA2—pancreas—pancreatic cancer	0.00255	0.0468	CbGeAlD
Mafenide—Diarrhoea—Irinotecan—pancreatic cancer	0.00254	0.00268	CcSEcCtD
Mafenide—Pruritus—Fluorouracil—pancreatic cancer	0.00251	0.00266	CcSEcCtD
Mafenide—Diarrhoea—Gemcitabine—pancreatic cancer	0.00247	0.00261	CcSEcCtD
Mafenide—Haemoglobin—Epirubicin—pancreatic cancer	0.00244	0.00259	CcSEcCtD
Mafenide—Haemorrhage—Epirubicin—pancreatic cancer	0.00243	0.00257	CcSEcCtD
Mafenide—Diarrhoea—Fluorouracil—pancreatic cancer	0.00243	0.00257	CcSEcCtD
Mafenide—Rash—Irinotecan—pancreatic cancer	0.00234	0.00247	CcSEcCtD
Mafenide—Dermatitis—Irinotecan—pancreatic cancer	0.00233	0.00247	CcSEcCtD
Mafenide—Rash—Gemcitabine—pancreatic cancer	0.00228	0.00241	CcSEcCtD
Mafenide—Dermatitis—Gemcitabine—pancreatic cancer	0.00227	0.00241	CcSEcCtD
Mafenide—Haemoglobin—Doxorubicin—pancreatic cancer	0.00226	0.00239	CcSEcCtD
Mafenide—Haemorrhage—Doxorubicin—pancreatic cancer	0.00225	0.00238	CcSEcCtD
Mafenide—Rash—Fluorouracil—pancreatic cancer	0.00224	0.00237	CcSEcCtD
Mafenide—Dermatitis—Fluorouracil—pancreatic cancer	0.00224	0.00236	CcSEcCtD
Mafenide—Pain—Docetaxel—pancreatic cancer	0.00219	0.00232	CcSEcCtD
Mafenide—CA2—digestive system—pancreatic cancer	0.00218	0.04	CbGeAlD
Mafenide—Erythema—Epirubicin—pancreatic cancer	0.00212	0.00224	CcSEcCtD
Mafenide—Erythema—Doxorubicin—pancreatic cancer	0.00196	0.00207	CcSEcCtD
Mafenide—Pruritus—Docetaxel—pancreatic cancer	0.00181	0.00192	CcSEcCtD
Mafenide—Diarrhoea—Docetaxel—pancreatic cancer	0.00175	0.00185	CcSEcCtD
Mafenide—Rash—Docetaxel—pancreatic cancer	0.00162	0.00171	CcSEcCtD
Mafenide—Dermatitis—Docetaxel—pancreatic cancer	0.00161	0.00171	CcSEcCtD
Mafenide—Pain—Epirubicin—pancreatic cancer	0.00148	0.00156	CcSEcCtD
Mafenide—Urticaria—Epirubicin—pancreatic cancer	0.00137	0.00145	CcSEcCtD
Mafenide—Pain—Doxorubicin—pancreatic cancer	0.00137	0.00145	CcSEcCtD
Mafenide—Urticaria—Doxorubicin—pancreatic cancer	0.00127	0.00134	CcSEcCtD
Mafenide—Pruritus—Epirubicin—pancreatic cancer	0.00122	0.00129	CcSEcCtD
Mafenide—Diarrhoea—Epirubicin—pancreatic cancer	0.00118	0.00125	CcSEcCtD
Mafenide—Pruritus—Doxorubicin—pancreatic cancer	0.00113	0.0012	CcSEcCtD
Mafenide—Diarrhoea—Doxorubicin—pancreatic cancer	0.00109	0.00116	CcSEcCtD
Mafenide—Rash—Epirubicin—pancreatic cancer	0.00109	0.00115	CcSEcCtD
Mafenide—Dermatitis—Epirubicin—pancreatic cancer	0.00109	0.00115	CcSEcCtD
Mafenide—Rash—Doxorubicin—pancreatic cancer	0.00101	0.00107	CcSEcCtD
Mafenide—Dermatitis—Doxorubicin—pancreatic cancer	0.00101	0.00107	CcSEcCtD
